WCLC: AstraZeneca’s detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win

WCLC: AstraZeneca’s detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win
aliu
Thu, 09/09/2021 – 08:07